Engineering SI-NET–specific IPMK mutations in mice would be an effective approach to clarify the role of IPMK in the development and progression of small intestinal neuroendocrine tumors (SI-NET). The gene discussed is IPMK; the disease is small intestine neuroendocrine neoplasm.